SCIARRONE, PAOLO
 Distribuzione geografica
Continente #
NA - Nord America 2.846
EU - Europa 1.914
AS - Asia 1.860
SA - Sud America 407
AF - Africa 56
Continente sconosciuto - Info sul continente non disponibili 35
OC - Oceania 7
Totale 7.125
Nazione #
US - Stati Uniti d'America 2.662
IT - Italia 760
SG - Singapore 656
RU - Federazione Russa 511
CN - Cina 424
BR - Brasile 319
VN - Vietnam 286
BD - Bangladesh 145
GB - Regno Unito 123
CA - Canada 116
DE - Germania 105
NL - Olanda 104
HK - Hong Kong 100
FR - Francia 80
SE - Svezia 56
IN - India 44
UA - Ucraina 36
IL - Israele 32
AR - Argentina 29
FI - Finlandia 29
MX - Messico 29
TR - Turchia 26
ID - Indonesia 23
PL - Polonia 22
AT - Austria 21
ES - Italia 20
ZA - Sudafrica 19
EC - Ecuador 18
JP - Giappone 18
PK - Pakistan 18
IQ - Iraq 17
CO - Colombia 12
UZ - Uzbekistan 12
IE - Irlanda 11
CR - Costa Rica 10
MA - Marocco 10
AE - Emirati Arabi Uniti 9
BE - Belgio 8
LT - Lituania 8
EG - Egitto 7
PY - Paraguay 7
VE - Venezuela 7
SA - Arabia Saudita 6
HN - Honduras 5
PE - Perù 5
PH - Filippine 5
CH - Svizzera 4
CL - Cile 4
NP - Nepal 4
NZ - Nuova Zelanda 4
TN - Tunisia 4
TW - Taiwan 4
UY - Uruguay 4
AZ - Azerbaigian 3
DO - Repubblica Dominicana 3
DZ - Algeria 3
JM - Giamaica 3
JO - Giordania 3
MY - Malesia 3
PS - Palestinian Territory 3
RO - Romania 3
AU - Australia 2
BB - Barbados 2
BG - Bulgaria 2
BO - Bolivia 2
CI - Costa d'Avorio 2
DM - Dominica 2
EU - Europa 2
GD - Grenada 2
GE - Georgia 2
GH - Ghana 2
GR - Grecia 2
GT - Guatemala 2
IR - Iran 2
KE - Kenya 2
KR - Corea 2
KZ - Kazakistan 2
LA - Repubblica Popolare Democratica del Laos 2
LB - Libano 2
MG - Madagascar 2
NI - Nicaragua 2
PR - Porto Rico 2
PT - Portogallo 2
QA - Qatar 2
SV - El Salvador 2
TT - Trinidad e Tobago 2
AL - Albania 1
AO - Angola 1
CW - ???statistics.table.value.countryCode.CW??? 1
CZ - Repubblica Ceca 1
EE - Estonia 1
ET - Etiopia 1
HU - Ungheria 1
KG - Kirghizistan 1
MK - Macedonia 1
MQ - Martinica 1
NO - Norvegia 1
OM - Oman 1
PA - Panama 1
SC - Seychelles 1
Totale 7.086
Città #
Dallas 464
Singapore 313
Ashburn 259
San Jose 245
Beijing 168
Council Bluffs 159
Moscow 95
Hong Kong 94
Los Angeles 92
Ho Chi Minh City 91
New York 82
Milan 80
Chandler 74
Rome 63
Hanoi 56
Fairfield 55
Santa Clara 55
São Paulo 42
The Dalles 35
Buffalo 34
Seattle 33
Munich 32
Phoenix 32
San Mateo 32
Ariccia 31
Florence 31
Lauterbourg 30
Ottawa 29
Pisa 29
Cambridge 28
Tel Aviv 28
Hefei 26
Montreal 26
Orem 26
Beauharnois 24
Houston 24
London 24
Wilmington 24
Boardman 22
Chicago 21
Falls Church 20
Frankfurt am Main 20
Atlanta 19
Jacksonville 19
Naples 18
Johannesburg 17
Poplar 16
Stevenage 16
Chennai 15
Denver 15
Tokyo 15
Helsinki 14
Portsmouth 14
Warsaw 14
Lawrence 13
Lucca 13
Mexico City 13
Woodbridge 13
Brooklyn 12
Nuremberg 12
Stockholm 12
Toronto 12
Ann Arbor 11
Biên Hòa 11
Brasília 11
Da Nang 11
Dong Ket 11
Dublin 11
Haiphong 11
Shanghai 11
Tashkent 11
Turin 11
Ankara 10
Rio de Janeiro 10
Genoa 9
Istanbul 9
Mumbai 9
Amsterdam 8
Karachi 8
Manaus 8
San Diego 8
Turku 8
Vienna 8
Bari 7
Charlotte 7
Fremont 7
Iowa City 7
Manchester 7
Paris 7
Querétaro 7
Quito 7
San Francisco 7
Bexley 6
Boston 6
Brussels 6
Düsseldorf 6
Figino 6
Hải Dương 6
Ninh Bình 6
Shenzhen 6
Totale 3.756
Nome #
Left ventricular outflow tract velocity-time integral improves outcome prediction in patients with secondary mitral regurgitation 642
An open computational toolbox to analyze multi- and single-unit sympathetic nerve activity in microneurography 379
[Central apneas and cardiovascular diseases] 357
Adaptive servo-ventilation therapy does not favourably alter sympatho-vagal balance in sleeping patients with systolic heart failure and central apnoeas: Preliminary data 352
Echocardiography-Derived Forward Left Ventricular Output Improves Risk Prediction in Systolic Heart Failure 308
Effects of central apneas on sympathovagal balance and hemodynamics at night: impact of underlying systolic heart failure 295
Central And Obstructive Apneas in Heart Failure With Reduced, Mid-Range And Preserved Ejection Fraction. 292
Effects of nasal high flow on sympathovagal balance, sleep, and sleep-related breathing in patients with precapillary pulmonary hypertension 273
Chemoreflex and Baroreflex Sensitivity Hold a Strong Prognostic Value in Chronic Heart Failure 258
Renin profiling predicts neurohormonal response to sacubitril/valsartan 256
Autonomic and respiratory consequences of altered chemoreflex function: clinical and therapeutic implications in cardiovascular diseases 254
null 253
Effects of hyperventilation length on muscle sympathetic nerve activity in healthy humans simulating periodic breathing 250
Sacubitril–valsartan treatment is associated with decrease in central apneas in patients with heart failure with reduced ejection fraction 237
Performance of risk stratification scores and role of comorbidities in older vs younger patients with pulmonary arterial hypertension 236
Central Apneas Are More Detrimental in Female Than in Male Patients With Heart Failure 234
Clinical and Prognostic Significance of sST2 in Heart Failure: JACC Review Topic of the Week 230
Non-Invasive Estimation of Right Atrial Pressure Using a Semi-Automated Echocardiographic Tool for Inferior Vena Cava Edge-Tracking 229
Remdesivir, Renal Function and Short-Term Clinical Outcomes in Elderly COVID-19 Pneumonia Patients: A Single-Centre Study 229
Incremental Prognostic Value of Echocardiography Measures of Right Ventricular Systolic Function in Patients With Chronic Heart Failure 226
Upright Cheyne-Stokes Respiration in Patients With Heart Failure 223
null 207
Decoding Ticagrelor Dyspnea: Central Apnea Screening Before Drug Discontinuation 201
Echocardiographic Estimate of Pulmonary Capillary Wedge Pressure Improves Outcome Prediction in Heart Failure Patients with Reduced and Mildly Reduced Ejection Fraction 194
null 192
Prognostic impact of diabetes in heart failure: looking back to move forward 152
Reply: Upright Cheyne-Stokes Respiration in Heart Failure: An Ominous Sign of Cardiovascular Dysregulation 61
Echocardiographic Estimation of Mean Pulmonary Artery Pressure: Head-to-Head Comparison of 5 Methods 43
Body mass index and outcomes in ischaemic versus non-ischaemic heart failure across the spectrum of ejection fraction 43
Novel drug targets for central apneas in heart failure: On the road 19
Totale 7.125
Categoria #
all - tutte 33.122
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 33.122


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022168 0 0 0 24 13 3 22 40 15 28 3 20
2022/2023154 13 24 8 17 18 23 1 13 22 2 6 7
2023/2024186 14 3 31 14 9 10 12 7 8 6 6 66
2024/20251.552 11 14 65 42 96 115 242 346 190 78 198 155
2025/20264.084 222 571 458 585 474 251 369 151 241 254 306 202
2026/2027658 120 140 264 134 0 0 0 0 0 0 0 0
Totale 7.125